|
Astal Laboratories Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
76.72 Cr.
|
P/BV
|
3.29
|
Book Value (Rs.)
|
23.73
|
|
52 Week High/Low (Rs.)
|
132/43
|
FV/ML
|
10/1
|
P/E(X)
|
97.81
|
|
Bookclosure
|
05/08/2024
|
EPS (Rs.)
|
0.80
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 1.55 | 0.04 | -0.04 | 0.02 | -0.07 |
| Diluted EPS (Rs.) | 1.55 | 0.04 | -0.04 | 0.02 | -0.07 |
| Cash EPS (Rs.) | 0.82 | 0.06 | -0.01 | 0.05 | -0.03 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.70 | 12.98 | 12.93 | 12.97 | 12.96 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.70 | 12.98 | 12.93 | 12.97 | 12.96 |
| Revenue From Operations / Share (Rs.) | 24.02 | 8.59 | 0.00 | 0.00 | 0.00 |
| PBDIT / Share (Rs.) | 1.14 | 0.10 | -0.01 | 0.05 | -0.03 |
| PBIT / Share (Rs.) | 1.11 | 0.08 | -0.04 | 0.02 | -0.07 |
| PBT / Share (Rs.) | 1.10 | 0.08 | -0.04 | 0.02 | -0.07 |
| Net Profit / Share (Rs.) | 0.79 | 0.04 | -0.04 | 0.01 | -0.07 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 4.76 | 1.16 | 0.00 | 0.00 | 0.00 |
| PBIT Margin (%) | 4.64 | 0.93 | 0.00 | 0.00 | 0.00 |
| PBT Margin (%) | 4.59 | 0.93 | 0.00 | 0.00 | 0.00 |
| Net Profit Margin (%) | 3.31 | 0.47 | 0.00 | 0.00 | 0.00 |
| Return on Networth / Equity (%) | 3.36 | 0.31 | -0.33 | 0.11 | -0.54 |
| Return on Capital Employeed (%) | 4.64 | 0.61 | -0.33 | 0.15 | -0.54 |
| Return On Assets (%) | 2.14 | 0.16 | -0.32 | 0.11 | -0.53 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 1.02 | 0.45 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.05 | 1.29 | 75.88 | 39.36 | 50.88 |
| Quick Ratio (X) | 1.97 | 1.29 | 75.88 | 39.36 | 50.88 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 104.34 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 73.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 34.48 | 11.72 | 6.44 | 3.46 | 3.65 |
| EV / Net Operating Revenue (X) | 1.46 | 3.42 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 30.60 | 293.86 | -2576.36 | 146.78 | -289.33 |
| MarketCap / Net Operating Revenue (X) | 1.70 | 3.44 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.72 | 2.28 | 1.25 | 0.67 | 0.70 |
| Price / Net Operating Revenue (X) | 1.70 | 3.44 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
